Transcending jurisdictional and party lines, elected officials from Spokane County and the city of Spokane met Friday for an ...

From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals last month.

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

For medical-technology and pharmaceuticals manufacturing, “the most effective answer is not tariffs but tax policy,” Johnson ...

EXCLUSIVE: Successfully ridding the U.S. of the effects of Mexico's criminal cartels operating along the southwestern border ...

EXCLUSIVE: Sens. Ron Johnson and Chuck Grassley are demanding information from the Justice Department’s inspector general on whether any unassigned, or "untasked," confidential human sources from DOJ ...

Reese Marketos played the role of government prosecutor in a False Claims Act case about alleged off-label use of an HIV drug ...

While J&J expects tariffs will cost it $400 million this year, the company maintained its earnings estimate and upped its ...

J&J’s comments and guidance update come as the company kicks off 2025’s first-quarter earnings round for large drugmakers.

Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall ...

Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain ...

Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of ...